The above is owing to a regulatory pathway for T cell activation associated to autoimmune diseases: the axis T cell Ig and ITIM domain (TIGIT) and CD226 (TIGIT/CD226) [21], was overexpressed in T cells from pSS patients. Here, CD226 is linked to autoimmune disease.